HighTower Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,700
Closed -$138K 3937
2025
Q1
$138K Buy
20,700
+2,952
+17% +$29.2K ﹤0.01% 3290
2024
Q4
$223K Sell
17,748
-1,073
-6% -$16.2K ﹤0.01% 3119
2024
Q3
$346K Sell
18,821
-5,556
-23% -$114K ﹤0.01% 2709
2024
Q2
$525K Buy
24,377
+165
+0.7% +$3.79K ﹤0.01% 2289
2024
Q1
$653K Sell
24,212
-3,504
-13% -$99.5K ﹤0.01% 2087
2023
Q4
$831K Sell
27,716
-1,000
-3% -$22.1K ﹤0.01% 1942
2023
Q3
$589K Sell
28,716
-1,613
-5% -$29.3K ﹤0.01% 2117
2023
Q2
$603K Sell
30,329
-117,400
-79% -$2.37M ﹤0.01% 2061
2023
Q1
$2.53M Buy
147,729
+55,175
+60% +$1.08M 0.01% 1154
2022
Q4
$1.81M Buy
92,554
+65,107
+237% +$1.2M ﹤0.01% 1344
2022
Q3
$439K Sell
27,447
-2,653
-9% -$41.4K ﹤0.01% 2104
2022
Q2
$416K Buy
30,100
+9,100
+43% +$108K ﹤0.01% 2158
2022
Q1
$336K Buy
21,000
+4,879
+30% +$84.3K ﹤0.01% 2439
2021
Q4
$351K Buy
16,121
+761
+5% +$20.8K ﹤0.01% 2384
2021
Q3
$460K Sell
15,360
-800
-5% -$29.1K ﹤0.01% 2102
2021
Q2
$716K Sell
16,160
-790
-5% -$34.3K ﹤0.01% 1839
2021
Q1
$750K Sell
16,950
-1,283
-7% -$70.4K ﹤0.01% 1735
2020
Q4
$1M Sell
18,233
-4,467
-20% -$163K ﹤0.01% 1260
2020
Q3
$518K Buy
22,700
+800
+4% +$19.7K ﹤0.01% 1550
2020
Q2
$458K Sell
21,900
-3,550
-14% -$64K ﹤0.01% 1512
2020
Q1
$356K Buy
25,450
+1,250
+5% +$24.8K ﹤0.01% 1480
2019
Q4
$552K Buy
+24,200
New +$404K ﹤0.01% 1404
2019
Q3
Sell
-10,000
Closed -$151K 2516
2019
Q2
$151K Hold
10,000
﹤0.01% 2105
2019
Q1
$176K Buy
+10,000
New +$158K ﹤0.01% 1981
2018
Q3
Sell
-21,344
Closed -$422K 2397
2018
Q2
$422K Buy
+21,344
New +$404K ﹤0.01% 1524

Other funds holding RCKT